Low Serum miR-607 Level as a Potential Diagnostic and Prognostic Biomarker in Patients of Pancreatic Ductal Adenocarcinoma: A Preliminary Study

Figure 2

The diagnostic value of miR-607 in patients with PDAC. (a) ROC curve analysis of miR-607 expression for discriminating PDAC tumor tissues from normal tissues. (b) ROC curve analysis based on serum miR-607, CA19-9, CEA, and their combination for differentiating PDAC patients from healthy controls. ROC: receiver operating characteristic, AUC: area under the curve.

(a)

(b)